Tisseel®
Pre-clinicalUNKNOWN 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Digital Nerve Injuries
Conditions
Digital Nerve Injuries
Trial Timeline
Mar 1, 2023 → Dec 31, 2025
NCT ID
NCT05490940About Tisseel®
Tisseel® is a pre-clinical stage product being developed by Baxter for Digital Nerve Injuries. The current trial status is unknown. This product is registered under clinical trial identifier NCT05490940. Target conditions include Digital Nerve Injuries.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05490940 | Pre-clinical | UNKNOWN |
| NCT00775034 | Approved | Completed |
Competing Products
1 competing product in Digital Nerve Injuries
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B | Sun Pharmaceutical | Phase 1 | 33 |